MedTrace Logo

Ultrasound-based Morphometry for the Development of Diagnostic and Prognostic Markers in Current and Chronic Diseases

NCT06829121 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2025-02-17

No results posted yet for this study

Summary

Frailty or debility is a geriatric syndrome that primarily affects older patients, but also patients with severe illnesses. It is particularly common among oncology patients, but also among patients with gastrointestinal diseases such as liver cirrhosis or pancreatitis. Sarcopenia, a component of frailty, is defined as a loss of muscle quantity, quality and function. Currently, complex methods such as CT or bioimpedance measurement are available. However, simpler techniques such as ultrasound-based measurement could be alternatives, but require further validation.

The aim of this project is to be able to estimate the prognosis of patients at an early stage by measuring sarcopenia using sonography.

Conditions

Interventions

DIAGNOSTIC_TEST

Ultrasound

The thickness of the psoas muscle and the musculus quadriceps femoris will be measured by ultrasound

Sponsors & Collaborators

  • Universitatsmedizin Mainz - 1. Medizinische Klinik

    lead OTHER

Principal Investigators

  • Wolfgang Maximilian Kremer WMK Kremer, MD · Universitatsmedizin Mainz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2022-05-20
Completion
2024-12-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06829121 on ClinicalTrials.gov